31 Mar 2023
Assets10.28
Total Income41.86
EBITDA1.14
Profit After Tax0.73
NET Worth2.71
Total Borrowing5.36
At a glance
Updated 2026-09-11Renol Polychem is a SME IPO with an issue size of ₹25.77 crore, proposed for listing on NSE SME. The offer opens on 31st Jul 2025 and closes on 4th Aug 2025. The issue structure includes a fresh issue of ₹24.20 crore.
Issue details
Listing atNSE SME
Issue typeBook Build Issue
Issue size₹25.77 Cr
Fresh issue₹24.20 Cr
Face value₹10
Price band₹100.00–₹105.00
Allotment5th Aug 2025
Listing7th Aug 2025
Grey market
GMP page ↗Latest GMP₹3.00
GMP / upper price2.86%
Est. listing₹108.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens31st Jul 2025
Closes4th Aug 2025
Allotment5th Aug 2025
Refund6th Aug 2025
Demat6th Aug 2025
Listing7th Aug 2025
Subscription demand
Full bidding ↗Total6.83×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 2400 | ₹252,000 |
Company
Incorporated2008
Use of proceeds
| Object | Amount |
|---|---|
| Capital Expenditure in requirements for the purchase of Machinery | ₹5.60 Cr |
| Repayment of certain borrowings | ₹1.00 Cr |
| To meet out the Working Capital Requirements | ₹15.15 Cr |
| General Corporate Purposes | ₹0.96 Cr |
| Issue Expenses | ₹3.06 Cr |
| Total | ₹25.77 Cr |
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue12.02₹ Cr · -80.8% vs prior year
EBITDA1.60₹ Cr · -77.4% vs prior year
PAT1.14₹ Cr · -77.2% vs prior year
Assets25.86₹ Cr · +10.5% vs prior year
Net Worth14.47₹ Cr · +8.6% vs prior year
Borrowing5.28₹ Cr · -24.0% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2024
Assets15.49
Total Income6.52
EBITDA2.18
Profit After Tax1.53
NET Worth8.69
Reserves and Surplus3.20
Total Borrowing2.58
31 Mar 2025
Assets23.41
Total Income62.56
EBITDA7.07
Profit After Tax5.00
NET Worth13.33
Reserves and Surplus7.84
Total Borrowing6.95
31 May 2025
Assets25.86
Total Income12.02
EBITDA1.60
Profit After Tax1.14
NET Worth14.47
Reserves and Surplus8.98
Total Borrowing5.28
KPIs
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 45.37% |
| ROCE | 64.18% |
| Debt / Equity | 0.52% |
| RoNW | 45.37% |
| PAT Margin | 8.02% |
| EBITDA Margin | 11.36% |
| Price to Book Value | 4.32 |
Valuation & shareholding
Pre-IPO EPS9.10
Post-IPO EPS8.62
Pre-IPO P/E11.54
Post-IPO P/E12.18
Promoter holding pre99.99%
Promoter holding post69.11%
Market cap₹83.41 Cr.
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Renol Polychem IPO | — | 12.18 x | — | — |
| Shanti Inorganic IPO | — | 16.63 x | — | — |
| Devson Catalyst IPO | — | 12.81 x | — | — |
| Biopol Chemicals IPO | — | 14.58 x | — | — |
Issue expenses
| Expense | Amount |
|---|---|
| Capital Expenditure in requirements for the purchase of Machinery | ₹5.60 Cr |
| Repayment of certain borrowings | ₹1.00 Cr |
| To meet out the Working Capital Requirements | ₹15.15 Cr |
| General Corporate Purposes | ₹0.96 Cr |
| Issue Expenses | ₹3.06 Cr |
| Total | ₹25.77 Cr |
Registrar & lead managers
Registrar
Skyline Financial Services Pvt.Ltd.Lead managers
- Corporate Makers Capital Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-11.
IPO UPDATE ALERTS
Register for IPO Updates →Track Renol Polychem without missing an update
Register for subscription, GMP, allotment and listing notifications.